Training activity information

Details

Report results for a patient receiving an immunotherapy, review the effectiveness, including at least three of the following:

  • Monoclonal antibody therapy
  • Immunosuppressive drugs
  • Physical methods of immunosuppression
  • Cytokines and anti-cytokines
  • Intravenous immunoglobulins
  • Immunisation against infection
  • Stem cell therapies
  • Gene therapies
  • Cell therapy

Type

Entrustable training activity (ETA)

Evidence requirements

Evidence the activity has been undertaken by the trainee repeatedly, consistently, and effectively over time, in a range of situations. This may include occasions where the trainee has not successfully achieved the outcome of the activity themselves. For example, because it was not appropriate to undertake the task in the circumstances or the trainees recognised their own limitations and sought help or advice to ensure the activity reached an appropriate conclusion. ​

Reflection at multiple timepoints on the trainee learning journey for this activity.

Considerations

  • Mechanism of immunotherapeutic interventions
  • Consequences of immunotherapeutic interventions
  • Monitoring tests
  • Follow on testing
  • Outcome measures
  • Local and national guidelines

Relevant learning outcomes

# Outcome
# 2 Outcome

Interpret and report on laboratory investigations that enumerate components of this immune system and its function in light of clinical details and other laboratory tests.